Navigation Links
Prosum Kicks Off Crowd Funding for Cancer Research
Date:8/9/2012

RENO, Nev., Aug. 9, 2012 /PRNewswire/ -- Prosum Breast Cancer Research, Inc. announces a Crowd Funding financing project to jump start its first research project to build the "You Will Be the Cure" for early detection breast health awareness and research. "Our first awareness project focuses on communicating individual experiences of women to educate all about the value with early detection starting at age 20," says Dave Wertzberger, Executive Director.

"We believe early detection education is much more than statistics and technology—women are the cure. The collective experience of survivors needs to be shared. We are convinced the profiles of women who have 'been there and done that' will provide invaluable awareness for women of all ages to advance the cure starting with early detection," adds Cindy Lain, Community Affairs Director.  "In addition, we see a number of early detection technologies coming to market and our goal is to confidentially involve volunteers with these technologies to improve device early detection usability and value," continues Wertzberger.

"Our Crowd Funding site at Rockethub.com provides one location to describe project goals and how individuals can support a new level of information for improving early detection and survival," says Wertzberger. "The Crowd Funding approach simplifies fund raising with contributions of $10, or more, while engaging folks wherever there is an Internet connection," says Wertzberger.

Prosum's awareness project will collect video histories as well as personal profiles in preparation for an updated web site for those who wish to share their stories to be part of our "You Will Be the Cure" awareness and research on early detection.  The fund raising goal is $30,000.  Any additional funds will be used to develop a confidential Breast Cancer History Database to improve early detection devices for positive change.

Press Ctrl, Click to follow the link
'/>"/>

SOURCE Prosum Breast Cancer Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
2. RD Legal Funding Provides Immediate Settlement Financing to Growing Number of Yaz and Yasmin Plaintiffs
3. DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
4. BONESUPPORT Closes Second Tranche of Funding
5. Elsevier and Russias Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding
6. Igenica Closes $33 Million in Series C Funding
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
9. Independa Closes Convertible Note Funding at $2.35 Million
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... , Oct. 2, 2014  AxelaCare Health Solutions, ... services, announced today that it has acquired Advanced Care, ... intravenous therapy provider.  Terms of the transaction were not ... AxelaCare,s intravenous solutions pharmacies to 18 nationwide and expands ... New York - New Jersey ...
(Date:10/2/2014)... Intarcia Therapeutics, Inc. today announced successful top-line results ... for ITCA 650 (exenatide, delivered continuously once or twice ... trial, FREEDOM-1, was a placebo-controlled, double-blind phase 3 clinical ... 650 in patients with type 2 diabetes against placebo. ... to placebo for both 40 mcg and 60 mcg ...
(Date:10/1/2014)... NOTTINGHAM, England , Oct. 1, 2014  Columbia ... that its subsidiary, Molecular Profiles Ltd., is set to ... annual CPhI/ICSE Worldwide event in Paris ... the rapid development of both standard and complex drug ... which incorporates the company,s existing formulation and analytical development ...
Breaking Medicine Technology:AxelaCare Health Solutions Acquires Advanced Care of New York 2AxelaCare Health Solutions Acquires Advanced Care of New York 3Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 2Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 3Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 4Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 5Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3
... Presented at the World Muscle Society International ... PTC Therapeutics, Inc.,(PTC), a biopharmaceutical company ... small-molecule drugs targeting,post-transcriptional control mechanisms, today announced ... of PTC124 in patients with Duchenne muscular,dystrophy ...
... Access Pharmaceuticals, Inc.,(OTC Bulletin Board: ACCP) ... clinical and preclinical data on its lead ... the American Association for,Cancer Research (AACR), National ... and Treatment of Cancer (EORTC) entitled,"International Conference ...
Cached Medicine Technology:PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 4Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 2
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, 2014 (HealthDay ... your risk for high blood pressure, a new study suggests. ... within 109 yards of a busy road had a 22 ... living at least half a mile away, researchers report. ... our physical environment on our health and well-being," said lead ...
(Date:10/2/2014)... by scientists at The University of Nottingham could lead ... painkiller. , A drug resulting from the research, published ... offer new hope to sufferers of chronic pain conditions ... painkillers are currently available. , The work, led by ... Sciences, in collaboration with David Bates, Professor of Oncology ...
(Date:10/1/2014)... modelling of the human eye, the brain of a ... and new technology, says a QUT leading robotics researcher. ... Engineering Faculty says the new study uses new computer ... high-density buildings or tunnels. , "This is a very ... putting two halves of a thing together because we,re ...
(Date:10/1/2014)... Familylifeinsurancequotes.org has released a new blog ... citizens. , Senior citizens can qualify for affordable ... to seniors who are over 50 years old. Some ... a medical examination. , Term life insurance with a ... can qualify. Having life insurance during retirement is important ...
(Date:10/1/2014)... Reno, Nev. (PRWEB) October 01, 2014 ... through measuring abnormal circadian cellular changes throughout the body, ... Health, Inc. to better address the company’s breadth of ... wearable early breast cancer screening technology. , “Our initial ... breast cancer system which detects abnormal circadian cellular changes ...
Breaking Medicine News(10 mins):Health News:Living Near a Highway May Be Bad for Your Blood Pressure 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 3Health News:Medical discovery first step on path to new painkillers 2Health News:Robot researcher combines nature to nurture 'superhuman' navigation 2Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4
... in our nation, Americans are very optimistic about the ... recent nationwide survey sponsored by Abbott, nearly two-thirds (64%) ... cancer. ,"As an organization researching new options ... efforts will live up to the optimism expressed by ...
... Suffering from acute or chronic lower back pain? There ... Medicine Center locally in Fairview, N.J, which will ... are only a handful of these machines in Bergen ... center, who administers non-invasive Intervertebral Disc Decompression (IDD) therapy. ...
... A teenage girl has died of bird flu in Indonesia, taking ... to 79, a health ministry official said Friday. ... to hospital on the main island of Java, the official said. ... chicken at her home in Kendal district in Central Java, said ...
... politician Abdel Aziz al-Hakim returned to Iraq's holy city of ... ,Hakim, the head of one of the most ... in a trip that included medical tests in the United ... his headquarters in Najaf and will be there for a ...
... earlier believed, a new study carried out by the ... ,According to the satellite-based research undertaken by Frank ... precipitation has also kept pace. ,The findings ... to accurately predict precipitation on regional scales. ...
... Scientists at the Chinese University in Hong Kong have identified ... may hold clues to male infertility . ,As part ... defective versions of the protein. They found that the sperms ... those of normal mice. ,'(The protein) is involved ...
Cached Medicine News:Health News:Americans Optimistic About the War on Cancer 2Health News:Indonesian Teenager Dies of Bird Flu 2Health News:Top Iraqi Shiite Leader Returns Home 2Health News:World may Get Much Wetter With Global Warming Than Believed 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: